It’s the GeneMedi’s summary page for Target/Biomarker Introduction of GABRA3. The page also collects GeneMedi’s different modalities and formats products for GABRA3 in therapeutics/drug discovery and IVD diagnostics, which is including antibody, ADC, bispecific, antigen, ORF vector, VLP, etc. With GeneMedi’s target-insight database-GM ITD database, the GABRA3 target is also connected to human indications/diseases/conditions/MOA.
Target sublocation: Transmembrane Protein.
GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. [provided by RefSeq, Jul 2008]